Literature DB >> 7865512

Grade 2 cellular heart rejection: does it exist?

M C Fishbein1, G Bell, M A Lones, L S Czer, J M Miller, D Harasty, A Trento.   

Abstract

According to the International Society for Heart and Lung Transplantation, a single focus of lymphocytic infiltration associated with myocyte injury in a cardiac allograft endomyocardial biopsy is focal moderate cellular rejection (Grade 2). We reviewed 115 endomyocardial biopsy specimens that were completely negative (n = 17), had a Quilty A (n = 17) or Quilty B (n = 46) lesion, or had a lesion fulfilling the criteria of grade 2 rejection (n = 35). By studying step sections (mean = 18) or sections stained for elastic tissue and collagen, we showed continuity of the focus of grade 2 rejection with the endocardium in 32 of 35 cases; these results justify reclassification of these foci as Quilty B lesions, which are defined as endocardial infiltrates that encroach on the underlying myocardium and that may be associated with myocyte injury but are not generally considered to represent acute rejection. Immunohistochemical staining for T and B lymphocytes and histiocytes showed similar patterns in deeper zones of Quilty B lesions and lesions initially regarded as grade 2 rejection. Normal hemodynamics were observed with 16 of 17 completely negative biopsy specimens, 16 of 17 Quilty A biopsy specimens, 46 of 46 Quilty B biopsy specimens, and 35 of 35 grade 2 rejection biopsy specimens. No grade 2 rejection was treated; only 1 biopsy specimen progressed to grade 3A rejection in a subsequent biopsy 2 months later. Most, if not all, cases of grade 2 cellular rejection can be shown to be Quilty B lesions, are not associated with hemodynamic abnormalities, and do not require augmented immunosuppression.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865512

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

1.  Revision of the 1990 working formulation for cardiac allograft rejection: the Sheffield experience.

Authors:  S K Suvarna; A Kennedy; F Ciulli; T J Locke
Journal:  Heart       Date:  1998-05       Impact factor: 5.994

2.  Enhanced lymphocyte longevity and absence of proliferation and lymphocyte apoptosis in Quilty effects of human heart allografts.

Authors:  C Dong; G L Winters; J E Wilson; B M McManus
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

3.  Conservative management of late rejection after heart transplantation: a 10-year analysis.

Authors:  J R Doty; P L Walinsky; J D Salazar; D E Alejo; P S Greene; W A Baumgartner
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

4.  Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection.

Authors:  Li Li; Kiran Khush; Szu-Chuan Hsieh; Lihua Ying; Helen Luikart; Tara Sigdel; Silke Roedder; Andrew Yang; Hannah Valantine; Minnie M Sarwal
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

5.  Diagnostic Pitfalls and Challenges in Interpretation of Heart Transplantation Rejection in Endomyocardial Biopsies With Focus on our Experience.

Authors:  Kambiz Mozaffari; Hooman Bakhshandeh; Ahmad Amin; Nasim Naderi; Sepideh Taghavi; Zahra Ojaghi-Haghighi; Mahsa Abdollahi
Journal:  Res Cardiovasc Med       Date:  2014-02-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.